Cargando…
LRRK2 Inhibits FAK Activity by Promoting FERM-mediated Autoinhibition of FAK and Recruiting the Tyrosine Phosphatase, SHP-2
Mutation of leucine-rich repeat kinase 2 (LRRK2) causes an autosomal dominant and late-onset familial Parkinson's disease (PD). Recently, we reported that LRRK2 directly binds to and phosphorylates the threonine 474 (T474)-containing Thr-X-Arg(Lys) (TXR) motif of focal adhesion kinase (FAK), th...
Autores principales: | Choi, Insup, Byun, Ji-won, Park, Sang Myun, Jou, Ilo, Joe, Eun-Hye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Brain and Neural Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081473/ https://www.ncbi.nlm.nih.gov/pubmed/27790061 http://dx.doi.org/10.5607/en.2016.25.5.269 |
Ejemplares similares
-
Small heterodimer partner (SHP) aggravates ER stress in Parkinson’s disease-linked LRRK2 mutant astrocyte by regulating XBP1 SUMOylation
por: Lee, Jee Hoon, et al.
Publicado: (2021) -
High resolution crystal structure of the FAK FERM domain reveals new insights on the Druggability of tyrosine 397 and the Src SH3 binding site
por: Marlowe, Timothy, et al.
Publicado: (2019) -
LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
por: Choi, Insup, et al.
Publicado: (2015) -
Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes
por: Lee, Jee Hoon, et al.
Publicado: (2019) -
Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma
por: Li, Ye, et al.
Publicado: (2021)